Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Certain skin symptoms can help detect and manage systemic lupus.

Early identification of lupus through skin signs and blood tests is crucial in India.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Tph cells are linked to the severity of systemic lupus erythematosus.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Fungal infections can cause hair loss in lupus patients and should be considered even if rare.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.